Glaxo (GSK) Rejects Unilever’s $68B Bid for Consumer Business Posted byZacks Equity Research January 17, 2022 Leave a comment on Glaxo (GSK) Rejects Unilever’s $68B Bid for Consumer Business Glaxo (GSK) rejects an offer from Unilever to acquire its consumer business worth 50 billion pounds ($68 billion). However, Unilever is likely to pursue the acquisition of the business.